来源：新浪证券-红岸工作室8月26日，海普瑞跌0.67%，成交额7142.24万元，换手率0.43%，总市值196.32亿元。异动分析创新药+生物疫苗+人民币贬值受益1、2024年年报，海普瑞于 1998 年成立于深圳，是拥有 A+H 双融资平台的领先跨国制药企业，主要业务覆盖肝素产业链、生物大分子 CDMO 和创新药物的投资、开发及商业化，致力于为全球患者带去高质量的安全有效药物和服务，护佑健康...
Source Link来源：新浪证券-红岸工作室8月26日，海普瑞跌0.67%，成交额7142.24万元，换手率0.43%，总市值196.32亿元。异动分析创新药+生物疫苗+人民币贬值受益1、2024年年报，海普瑞于 1998 年成立于深圳，是拥有 A+H 双融资平台的领先跨国制药企业，主要业务覆盖肝素产业链、生物大分子 CDMO 和创新药物的投资、开发及商业化，致力于为全球患者带去高质量的安全有效药物和服务，护佑健康...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.